Physician profile
Joseph A Cabaret
NPI 1689600041
$7,275.72
in general payments reported to CMS, 2019-2025
35 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $976 · 2020: $100 · 2021: $1,408 · 2022: $1,454 · 2023: $1,801 · 2024: $1,120 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,337.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,969.66 | 2021-2025 | Accurian, Intellis Adaptivestim, Inceptiv |
| Relievant Medsystems, INC. | $748.21 | 2021-2023 | Intracept |
| Medtronic USA, INC. | $440.71 | 2019-2020 | |
| Abbvie INC. | $435.52 | 2021-2025 | Botox, Ubrelvy |
| Neuronetics, INC. | $317.50 | 2022-2023 | Neurostar Tms Therapy System |
| Boston Scientific Corporation | $240.03 | 2021-2024 | Superion Indirect Decompression System |
| Nevro Corp. | $226.07 | 2021 | |
| Collegium Pharmaceutical, INC. | $218.49 | 2019-2025 | Belbuca, Xtampza |
| Abbott Laboratories | $216.76 | 2019 | |
| Amgen INC. | $140.67 | 2019-2022 | |
| Stimwave Technologies Incorporated | $119.49 | 2021-2022 | |
| Indivior INC. | $98.27 | 2019 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Almatica Pharma LLC | $96.24 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $94.42 | 2024-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $89.56 | 2021 | |
| Painteq LLC | $80.43 | 2022-2023 | Painteq |
| Spr Therapeutics, INC | $73.31 | 2024 | Sprint Pns System |
| Arbor Pharmaceuticals, INC. | $67.55 | 2021 | |
| Depuy Synthes Sales INC. | $63.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.01 | 2019-2020 | |
| Tersera Therapeutics LLC | $45.58 | 2019 | |
| Lundbeck LLC | $44.73 | 2021-2022 | |
| Biotronik Nro, INC. | $37.09 | 2025 | Prospera |
| Pfizer INC. | $34.79 | 2019-2024 | |
| Scilex Pharmaceuticals INC. | $33.52 | 2022 | |
| Biodelivery Sciences International, INC. | $29.84 | 2019-2021 | |
| Flowonix Medical Incorporated | $28.74 | 2019 | |
| Alkermes, INC. | $23.00 | 2023 | Vivitrol |
| Allergan, INC. | $21.02 | 2022 | |
| Mml US, INC. | $20.65 | 2025 | Reactiv8 |
| Teva Pharmaceuticals USA, INC. | $19.39 | 2019 | |
| Saluda Medical Americas, INC. | $17.13 | 2024 | Evoke |
| Tonix Medicines, INC. | $15.55 | 2025 | Tonmya |
| Vertiflex, INC. | $15.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cabaret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.